{"info": {"address1": "910 Clopper Road", "address2": "Suite 201S", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 654 1450", "website": "https://altimmune.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 59, "companyOfficers": [{"maxAge": 1, "name": "Dr. Vipin K. Garg Ph.D.", "age": 66, "title": "President, CEO & Director", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 992999, "exercisedValue": 0, "unexercisedValue": 1959778}, {"maxAge": 1, "name": "Dr. M. Scot Roberts Ph.D.", "age": 65, "title": "Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 648960, "exercisedValue": 0, "unexercisedValue": 290514}, {"maxAge": 1, "name": "Mr. Gregory L. Weaver CPA, M.B.A.", "age": 68, "title": "Chief Financial Officer", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Shutterly M.S.", "age": 36, "title": "Principal Financial & Accounting Officer and Corporate Controller", "yearBorn": 1988, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bertrand  Georges Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tony  Blandin B.S.", "title": "Vice President of Quality & Compliance Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Robin E. Abrams J.D.", "age": 60, "title": "General Counsel & Chief Legal Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Raymond M. Jordt M.B.A.", "age": 51, "title": "Chief Business Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 578850, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Linda M. Richardson", "age": 60, "title": "Chief Commercial Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christophe  Arbet-Engels M.B.A., M.D., Ph.D.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 4, "overallRisk": 6, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://ir.pharmathene.com/phoenix.zhtml?c=191999&p=irol-irhome", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.19, "open": 4.15, "dayLow": 4.0905, "dayHigh": 4.7286, "regularMarketPreviousClose": 4.19, "regularMarketOpen": 4.15, "regularMarketDayLow": 4.0905, "regularMarketDayHigh": 4.7286, "exDividendDate": 1484870400, "payoutRatio": 0.0, "beta": -0.013, "forwardPE": -3.1632652, "volume": 4264813, "regularMarketVolume": 4264813, "averageVolume": 2802192, "averageVolume10days": 3309370, "averageDailyVolume10Day": 3309370, "bid": 3.38, "ask": 5.28, "bidSize": 2, "askSize": 2, "marketCap": 485192096, "fiftyTwoWeekLow": 2.9, "fiftyTwoWeekHigh": 10.88, "allTimeHigh": 137.7, "allTimeLow": 1.51, "priceToSalesTrailing12Months": 24259.605, "fiftyDayAverage": 3.9288, "twoHundredDayAverage": 4.8001, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 289910912, "profitMargins": 0.0, "floatShares": 103560883, "sharesOutstanding": 104342385, "sharesShort": 21780366, "sharesShortPriorMonth": 26194292, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.20889999, "heldPercentInsiders": 0.00672, "heldPercentInstitutions": 0.40612, "shortRatio": 7.95, "shortPercentOfFloat": 0.21020001, "impliedSharesOutstanding": 104342385, "bookValue": 1.941, "priceToBook": 2.3956723, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -83915000, "trailingEps": -1.19, "forwardEps": -1.47, "lastSplitFactor": "1:30", "lastSplitDate": 1536883200, "enterpriseToRevenue": 14495.545, "enterpriseToEbitda": -3.209, "52WeekChange": -0.43908972, "SandP52WeekChange": 0.1276716, "quoteType": "EQUITY", "currentPrice": 4.65, "targetHighPrice": 28.0, "targetLowPrice": 1.0, "targetMeanPrice": 16.55556, "targetMedianPrice": 18.0, "recommendationMean": 1.88889, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 210776000, "totalCashPerShare": 2.022, "ebitda": -90343000, "totalDebt": 15905000, "quickRatio": 16.831, "currentRatio": 17.183, "totalRevenue": 20000, "debtToEquity": 8.569, "revenuePerShare": 0.0, "returnOnAssets": -0.30868998, "returnOnEquity": -0.52615, "grossProfits": -67784000, "freeCashflow": -37671376, "operatingCashflow": -66352000, "revenueGrowth": 0.0, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -4171.8, "financialCurrency": "USD", "symbol": "ALT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1763513078, "regularMarketTime": 1763499602, "exchange": "NGM", "messageBoardId": "finmb_4866807", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 10.978521, "regularMarketPrice": 4.65, "shortName": "Altimmune, Inc.", "marketState": "POST", "priceEpsCurrentYear": -4.710578, "fiftyDayAverageChange": 0.7212, "fiftyDayAverageChangePercent": 0.1835675, "twoHundredDayAverageChange": -0.15009975, "twoHundredDayAverageChangePercent": -0.03127013, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.9 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1495805400000, "postMarketChangePercent": 0.423657, "postMarketPrice": 4.6697, "postMarketChange": 0.01970005, "regularMarketChange": 0.46000004, "regularMarketDayRange": "4.0905 - 4.7286", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 2802192, "fiftyTwoWeekLowChange": 1.75, "fiftyTwoWeekLowChangePercent": 0.6034483, "fiftyTwoWeekRange": "2.9 - 10.88", "fiftyTwoWeekHighChange": -6.23, "fiftyTwoWeekHighChangePercent": -0.5726103, "fiftyTwoWeekChangePercent": -43.90897, "dividendDate": 1536883200, "earningsTimestamp": 1762435800, "earningsTimestampStart": 1762435800, "earningsTimestampEnd": 1762435800, "earningsCallTimestampStart": 1762435800, "earningsCallTimestampEnd": 1762435800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.19, "epsForward": -1.47, "epsCurrentYear": -0.98714, "longName": "Altimmune, Inc.", "displayName": "Altimmune", "trailingPegRatio": null}, "info_ts": "2025-11-19T00:45:01.311709+00:00"}